Thesis (Ph. D.)--University of Rhode Island, 2003. / Typescript. Includes bibliographical references (leaves 286-304).

Thesis (Ph. D.)--University of Texas at Austin, 2000. / Vita. Includes bibliographical references (leaves 193-209). Available also in a digital version from Dissertation Abstracts.

Thesis (M. Soc. Sc.)--University of Hong Kong, 1992.

Thesis (Ph. D.)--University of Wisconsin-- Madison, 1975. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 60-62).

Thesis (Ph. D.)--University of Washington, 1995. / Vita. Includes bibliographical references (leaves [175]-192).

Thesis (Ph. D.)--University of Sydney, 1998. / Title from title screen (viewed 10 September, 2008). Submitted in fulfillment of the requirements for the degree of Doctor of Philosophy to the Dept. of English, Faculty of Arts. Includes bibliographical references. Also available in print form.

Thesis (M.Soc.Sc.)--University of Hong Kong, 1992. / Also available in print.

Thesis (Ph. D.)--University of Washington, 2006. / Vita. Includes bibliographical references (leaves 73-87).

Thesis (Ph. D.)--University of Texas at Austin, 1999. / Vita. Includes bibliographical references (leaves 162-164). Available also in a digital version from Dissertation Abstracts.

Thesis (Ph.D.)--Boston University / Since chlorpromazine was first developed it has found widespread use in the treatment of various mental dis orders, particularly schizophrenia. Research to date has suggested that the drug has an adverse effect on some psychological functions and a beneficial effect on others, particularly in the area of clinical symptoms. While some studies have led to the conclusion that the drug reduces the symptoms of psychiatric patients, other studies often do not support that conclusion. In the stuiies where psychiatric patients have been used as subjects for laboratory tasks, it has usually been assumed that the patient's psychiatric state has a detrimental effect on the performance of the task and it has been hypot he sized that chlorpromazine will increase task efficiency. The purpose of this study was to test the effect of chlorpromazine hydrochloride on stress-induced anxiety. There has been little effort to manipulate experimentally the emotional state of the subject and then to test the drug's ability to reduce the emotional state. One study, using normal human subjects, found that the drug did not reduce the detrimental effects of psychological stress. Two animal studies, however, indicated that the drug hastened the extinction of conditioned fear responses. [TRUNCATED]